https://www.selleckchem.com/pr....oducts/lixisenatide.
In the full-analysis set, 87.0% of the patients were "responders" (95% confidence interval 81.7-91.3%). In 148 patients, the optimum dose was low (0.5mg in 99, and 1mg in 49), with patients finishing the study on days 4-8. Following dose escalation to 4mg, respiratory depression occurred in one patient; however, this was considered a mild adverse event. A low-dose fentanyl citrate patch was effective in the management of cancer pain in opioid-naïve patients and was well tolerated. JPRN-JapicCTI-173717. JPRN-JapicCTI-173717.There is
Like
Comment
Share
